Literature DB >> 15618051

Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study.

Renate Schnabel1, Hans J Rupprecht, Karl J Lackner, Edith Lubos, Christoph Bickel, Jürgen Meyer, Thomas Münzel, François Cambien, Laurence Tiret, Stefan Blankenberg.   

Abstract

AIMS: N-terminal-pro-brain natriuretic peptide (Nt-proBNP) is a reliable risk predictor in acute coronary artery disease (CAD). Little is known about patients with stable angina pectoris (SAP). We aimed to investigate the prognostic impact of Nt-proBNP in a population with CAD especially focussing on patients with SAP. METHODS AND
RESULTS: We obtained baseline samples from a prospective cohort of 904 consecutive patients with CAD. Cardiovascular events were registered during follow-up (median 2 years; maximum 3.7 years). Baseline Nt-proBNP was significantly higher among individuals with cardiovascular events compared with those without (711.5 vs. 238.8 pg/mL; P<0.0001). A similar association was found if the analysis was performed in patients who presented with stable angina (330 vs. 166.5 pg/mL; P=0.006) or acute coronary syndrome (990.9 vs. 527.7 pg/mL; P=0.03). In the SAP group, patients within the top quartile (>487.9 pg/mL) had a 3.7-fold (95% CI 1.2-9.1; P=0.01) increase in cardiovascular risk. After adjustment for most potential confounders including left ventricular ejection fraction, Nt-proBNP remained predictive for patients with serum concentrations in the upper quartile in comparison with patients in the lowest quartile (hazard ratio highest vs. lowest quartile: 4.0; P=0.03) (n=417).
CONCLUSION: Baseline concentration of Nt-proBNP is independently related to future cardiovascular events in patients with stable angina.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15618051     DOI: 10.1093/eurheartj/ehi036

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

1.  Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery.

Authors:  Harm H H Feringa; Olaf Schouten; Martin Dunkelgrun; Jeroen J Bax; Eric Boersma; Abdou Elhendy; Robert de Jonge; Stefanos E Karagiannis; Radosav Vidakovic; Don Poldermans
Journal:  Heart       Date:  2006-08-16       Impact factor: 5.994

2.  N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.

Authors:  Kirsten Bibbins-Domingo; Reena Gupta; Beeya Na; Alan H B Wu; Nelson B Schiller; Mary A Whooley
Journal:  JAMA       Date:  2007-01-10       Impact factor: 56.272

Review 3.  Current status of risk stratification methods in acute coronary syndromes.

Authors:  Raphael See; James A de Lemos
Journal:  Curr Cardiol Rep       Date:  2006-07       Impact factor: 2.931

4.  B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide - Diagnostic role in stable coronary artery disease.

Authors:  Michael Weber; Veselin Mitrovic; Christian Hamm
Journal:  Exp Clin Cardiol       Date:  2006

5.  Ischemia/reperfusion is an independent trigger for increasing myocardial content of mRNA B-type natriuretic peptide.

Authors:  Lafayete William F Ramos; Neif Murad; Eduardo Goto; Edinei L Antônio; José A Silva; Paulo F Tucci; Antônio C Carvalho
Journal:  Heart Vessels       Date:  2009-11-22       Impact factor: 2.037

6.  Evaluation of N-terminal prohormone B-type natriuretic Peptide in patients with acute coronary syndromes and percutaneous coronary intervention.

Authors:  Konstantinos M Lampropoulos; Andreas Marinakis; Dimitrios P Sokolis; Themistoklis A Iliopoulos
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-11       Impact factor: 3.738

7.  B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina.

Authors:  Ricardo León de la Fuente; Patrycja A Naesgaard; Stein Tore Nilsen; Leik Woie; Torbjoern Aarsland; Patricio Gallo; Heidi Grundt; Harry Staines; Dennis W T Nilsen
Journal:  BMC Cardiovasc Disord       Date:  2011-09-29       Impact factor: 2.298

Review 8.  Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies.

Authors:  Peter Willeit; Daniel F Freitag; Jari A Laukkanen; Susmita Chowdhury; Reeta Gobin; Manuel Mayr; Emanuele Di Angelantonio; Rajiv Chowdhury
Journal:  J Am Heart Assoc       Date:  2015-05-28       Impact factor: 5.501

9.  B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study.

Authors:  Trygve Brügger-Andersen; Volker Pönitz; Harry Staines; David Pritchard; Heidi Grundt; Dennis W T Nilsen
Journal:  BMC Cardiovasc Disord       Date:  2008-11-25       Impact factor: 2.298

Review 10.  Natriuretic peptides in cardiovascular diseases.

Authors:  Mariusz Piechota; Maciej Banach; Anna Jacoń; Jacek Rysz
Journal:  Cell Mol Biol Lett       Date:  2008-04-10       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.